- Home
- OPOF vs SGHT Comparison
OPOF vs SGHT Comparison
Compare OPOF & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPOF
- SGHT
- Stock Information
- Founded
- OPOF 1922
- SGHT 2011
- Country
- OPOF United States
- SGHT United States
- Employees
- OPOF N/A
- SGHT N/A
- Industry
- OPOF Major Banks
- SGHT Medical Specialities
- Sector
- OPOF Finance
- SGHT Health Care
- Exchange
- OPOF Nasdaq
- SGHT Nasdaq
- Market Cap
- OPOF 212.5M
- SGHT 179.7M
- IPO Year
- OPOF N/A
- SGHT 2021
- Fundamental
- Price
- OPOF N/A
- SGHT $3.69
- Analyst Decision
- OPOF
- SGHT Buy
- Analyst Count
- OPOF 0
- SGHT 8
- Target Price
- OPOF N/A
- SGHT $4.29
- AVG Volume (30 Days)
- OPOF 31.3K
- SGHT 125.0K
- Earning Date
- OPOF 10-23-2025
- SGHT 11-06-2025
- Dividend Yield
- OPOF 1.33%
- SGHT N/A
- EPS Growth
- OPOF 21.17
- SGHT N/A
- EPS
- OPOF 1.70
- SGHT N/A
- Revenue
- OPOF $61,004,000.00
- SGHT $76,303,000.00
- Revenue This Year
- OPOF N/A
- SGHT N/A
- Revenue Next Year
- OPOF N/A
- SGHT $11.32
- P/E Ratio
- OPOF $24.72
- SGHT N/A
- Revenue Growth
- OPOF 4.45
- SGHT N/A
- 52 Week Low
- OPOF $17.02
- SGHT $2.03
- 52 Week High
- OPOF $42.68
- SGHT $7.03
- Technical
- Relative Strength Index (RSI)
- OPOF 5.67
- SGHT 39.74
- Support Level
- OPOF $40.71
- SGHT $4.09
- Resistance Level
- OPOF $42.43
- SGHT $4.25
- Average True Range (ATR)
- OPOF 0.56
- SGHT 0.16
- MACD
- OPOF -2.62
- SGHT -0.07
- Stochastic Oscillator
- OPOF 0.00
- SGHT 9.16
About OPOF Old Point Financial Corporation
Old Point Financial Corp functions in the financial services domain in the United States. As the holding company of The Bank and Trust, it is a nationally chartered trust and wealth management service, provider. Its suite of services includes commercial banking solutions such as loan, deposit and cash management, which are rendered through a chain of branches throughout the country. It operates through segments such as Bank, Wealth and Company.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.